{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:20:57Z","timestamp":1792189257266,"version":"4.4.0"},"reference-count":0,"publisher":"Oxford University Press (OUP)","issue":"suppl_1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2000,10,1]]},"DOI":"10.1093\/ajhp\/57.suppl_1.s3","type":"journal-article","created":{"date-parts":[[2019,1,3]],"date-time":"2019-01-03T06:59:12Z","timestamp":1546498752000},"page":"S3-S7","source":"Crossref","is-referenced-by-count":94,"title":["Overview of the angiotensin-converting-enzyme inhibitors"],"prefix":"10.1093","volume":"57","author":[{"given":"Robert W.","family":"Piepho","sequence":"first","affiliation":[{"name":"School of Pharmacy, University of Missouri\u2014Kansas City, 505 Rockhill Road, Kansas City, MO 64110"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajhp\/article-pdf\/57\/suppl_1\/S3\/28426561\/ajhp00s3.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,15]],"date-time":"2019-04-15T13:59:02Z","timestamp":1555336742000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/57\/suppl_1\/S3\/5156955"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,10,1]]},"references-count":0,"journal-issue":{"issue":"suppl_1","published-print":{"date-parts":[[2000,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ajhp\/57.suppl_1.s3","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2000,10,1]]},"published":{"date-parts":[[2000,10,1]]}}}